Rift valley fever virus MP-12 vaccine encoding toscana virus NSs retains neuroinvasiveness in mice

Journal of General Virology

Volumn 94, Issue PART7, 2013, Pages 1441-1450

  Indran, Sabarish V ^a,c   Lihoradova, Olga A ^a   Phoenix, Inaia ^a   Lokugamage, Nandadeva ^a   Kalveram, Birte ^a   Head, Jennifer A ^a   Tigabu, Bersabeh ^a   Smith, Jennifer K ^a,b   Zhang, Lihong ^a,b   Juelich, Terry L ^a,b   Gong, Bin ^a,b   Freiberg, Alexander N ^a,b   Ikegami, Tetsuro ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DOUBLE STRANDED RNA; MP 12; PROTEIN KINASE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VACCINE;

AFRICA SOUTH OF THE SAHARA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENE CONTROL; GENETIC TRANSCRIPTION; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LIVER; MEDULLA OBLONGATA; MOUSE; NONHUMAN; OUTBRED STRAIN; PHLEBOVIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; RNA DEGRADATION; SPLEEN; THALAMUS; TOSCANA VIRUS; UPREGULATION; VIRAL GENETICS; VIRUS DETECTION; VIRUS REPLICATION;

ANIMALS; BRAIN; CELL LINE; CERCOPITHECUS AETHIOPS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NERVOUS SYSTEM DISEASES; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SANDFLY FEVER NAPLES VIRUS; VACCINATION; VACCINES, ATTENUATED; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

ANIMALIA; BUNYAVIRIDAE; MUS; PHLEBOVIRUS; RIFT VALLEY FEVER VIRUS; TOSCANA VIRUS;

EID: 84879131368     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.051250-0     Document Type: Article

References (44)

1. Anderson, G. W., Jr, Slone, T. W., Jr & Peters, C. J. (1988). The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis. Arch Virol 102, 187-196.
2. Austin, D., Baer, A., Lundberg, L., Shafagati, N., Schoonmaker, A., Narayanan, A., Popova, T., Panthier, J. J., Kashanchi, F. & other authors (2012). p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production. PLoS ONE 7, e36327.
3. Baer, A., Austin, D., Narayanan, A., Popova, T., Kainulainen, M., Bailey, C., Kashanchi, F., Weber, F. & Kehn-Hall, K. (2012). Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication. J Biol Chem 287, 7399-7410.
4. Billecocq, A., Gauliard, N., Le May, N., Elliott, R. M., Flick, R. & Bouloy, M. (2008). RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology 378, 377-384.
5. Bird, B. H., Albariño, C. G. & Nichol, S. T. (2007). Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology 362, 10-15.
6. Bouloy, M., Janzen, C., Vialat, P., Khun, H., Pavlovic, J., Huerre, M. & Haller, O. (2001). Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75, 1371-1377.
7. Caplen, H., Peters, C. J. & Bishop, D. H. (1985). Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 66, 2271-2277.
8. Cêtre-Sossah, C., Zeller, H., Grandadam, M., Caro, V., Pettinelli, F., Bouloy, M., Cardinale, E. & Albina, E. (2012). Genome analysis of Rift Valley fever virus, Mayotte. Emerg Infect Dis 18, 969-971.
9. Daubney, R., Hudson, J. R. & Garnham, P. C. (1931). Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep cattle and man from east Africa. J Pathol Bacteriol 34, 545-579.
10. Fernandez, J. C., Billecocq, A., Durand, J. P., Cêtre-Sossah, C., Cardinale, E., Marianneau, P., Pépin, M., Tordo, N. & Bouloy, M. (2012). The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus. Clin Vaccine Immunol 19, 5-10.
11. Gale, M., Jr, Tan, S. L. & Katze, M. G. (2000). Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev 64, 239-280.
12. Gori Savellini, G., Weber, F., Terrosi, C., Habjan, M., Martorelli, B. & Cusi, M. G. (2011). Toscana virus induces interferon although its NSs protein reveals antagonistic activity. J Gen Virol 92, 71-79.
13. Grobbelaar, A. A., Weyer, J., Leman, P. A., Kemp, A., Paweska, J. T. & Swanepoel, R. (2011). Molecular epidemiology of Rift Valley fever virus. Emerg Infect Dis 17, 2270-2276.
14. Habjan, M., Pichlmair, A., Elliott, R. M., Overby, A. K., Glatter, T., Gstaiger, M., Superti-Furga, G., Unger, H. & Weber, F. (2009). NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 83, 4365-4375.
15. Ikegami, T. (2012). Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res 95, 293-310.
16. Ikegami, T. & Makino, S. (2011). The pathogenesis of Rift Valley fever. Viruses 3, 493-519.
17. Ikegami, T., Won, S., Peters, C. J. & Makino, S. (2006). Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80, 2933-2940.
18. Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C. J. & Makino, S. (2009). Rift Valley fever virus NSs protein promotes posttranscriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 5, e1000287.
19. Ito, N., Takayama-Ito, M., Yamada, K., Hosokawa, J., Sugiyama, M. & Minamoto, N. (2003). Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol 47, 613-617.
20. Kalveram, B. & Ikegami, T. (2013). Toscana Virus NSs Protein Promotes Degradation of Double-Stranded RNA-Dependent Protein Kinase. J Virol 87, 3710-3718.
21. Kalveram, B., Lihoradova, O. & Ikegami, T. (2011a). NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J Virol 85, 6234-6243.
22. Kalveram, B., Lihoradova, O., Indran, S. V. & Ikegami, T. (2011b). Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy. J Vis Exp 57, e3400.
23. Kalveram, B., Lihoradova, O., Indran, S. V., Lokugamage, N., Head, J. A. & Ikegami, T. (2013). Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. Virology 435, 415-424.
24. Le May, N., Dubaele, S., De Santis, L. P., Billecocq, A., Bouloy, M. & Egly, J. M. (2004). TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116, 541-550.
25. Le May, N., Mansuroglu, Z., Léger, P., Josse, T., Blot, G., Billecocq, A., Flick, R., Jacob, Y., Bonnefoy, E. & Bouloy, M. (2008). A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 4, e13.
26. Lihoradova, O., Kalveram, B., Indran, S. V., Lokugamage, N., Juelich, T. L., Hill, T. E., Tseng, C. T., Gong, B., Fukushi, S. & other authors (2012). The dominant-negative inhibition of double-stranded RNAdependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine. J Virol 86, 7650-7661.
27. Linthicum, K. J., Davies, F. G., Kairo, A. & Bailey, C. L. (1985). Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya. J Hyg (Lond) 95, 197-209.
28. Lokugamage, N., Freiberg, A. N., Morrill, J. C. & Ikegami, T. (2012). Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains. J Virol 86, 13566-13575.
29. Mansuroglu, Z., Josse, T., Gilleron, J., Billecocq, A., Leger, P., Bouloy, M. & Bonnefoy, E. (2010). Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. J Virol 84, 928-939.
30. McElroy, A. K., Albariño, C. G. & Nichol, S. T. (2009). Development of a RVFV ELISA that can distinguish infected from vaccinated animals. Virol J 6, 125.
31. Morrill, J. C., Jennings, G. B., Caplen, H., Turell, M. J., Johnson, A. J. & Peters, C. J. (1987). Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res 48, 1042-1047.
32. Morrill, J. C., Carpenter, L., Taylor, D., Ramsburg, H. H., Quance, J. & Peters, C. J. (1991). Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine 9, 35-41.
33. Morrill, J. C., Mebus, C. A. & Peters, C. J. (1997a). Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am J Vet Res 58, 1104-1109.
34. Morrill, J. C., Mebus, C. A. & Peters, C. J. (1997b). Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am J Vet Res 58, 1110-1114.
35. Morrill, J. C., Ikegami, T., Yoshikawa-Iwata, N., Lokugamage, N., Won, S., Terasaki, K., Zamoto-Niikura, A., Peters, C. J. & Makino, S. (2010). Rapid accumulation of virulent Rift Valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. PLoS ONE 5, e9986.
36. Morrill, J. C., Laughlin, R. C., Lokugamage, N., Pugh, R., Sbrana, E., Weise, W. J., Adams, L. G., Makino, S. & Peters, C. J. (2013). Safety and immunogenicity of recombinant Rift Valley Fever MP-12 vaccine candidates in sheep. Vaccine 31, 559-565.
37. Pepin, M., Bouloy, M., Bird, B. H., Kemp, A. & Paweska, J. (2010). Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41, 61.
38. Schmaljohn, C. & Nichol, S. T. (2007). Bunyaviridae. In Fields Virology, 5th edn, pp. 1741-1789. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus. Philadelphia, PA: Lipincott, Williams & Wilkins.
39. Smith, D. R., Steele, K. E., Shamblin, J., Honko, A., Johnson, J., Reed, C., Kennedy, M., Chapman, J. L. & Hensley, L. E. (2010). The pathogenesis of Rift Valley fever virus in the mouse model. Virology 407, 256-267.
40. Swanepoel, R. & Coetzer, J. A. W. (2004). Rift Valley fever. In Infectious Diseases of Livestock with Special Reference to Southern Africa, 2nd edn, pp. 1037-1070. Edited by J. A. W. Coetzer & R. C. Tustin. Cape Town, South Africa: Oxford University Press.
41. Tesh, R. B. (1988). The genus Phlebovirus and its vectors. Annu Rev Entomol 33, 169-181.
42. Wang, T., Town, T., Alexopoulou, L., Anderson, J. F., Fikrig, E. & Flavell, R. A. (2004). Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10, 1366-1373.
43. Xu, F., Chen, H., Travassos da Rosa, A. P., Tesh, R. B. & Xiao, S. Y. (2007). Phylogenetic relationships among sandfly fever group viruses (Phlebovirus: Bunyaviridae) based on the small genome segment. J Gen Virol 88, 2312-2319.
44. Yang, Y. L., Reis, L. F., Pavlovic, J., Aguzzi, A., Schäfer, R., Kumar, A., Williams, B. R., Aguet, M. & Weissmann, C. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 14, 6095-6106.